Drugs
?
-
Radiation Emergencies
Drug Information Related to Radiation Emergencies
- Calcium-DTPA and Zinc-DTPA
Conditions under which calcium-DTPA (Ca-DTPA) and zinc-DTPA (Zn-DTPA) can be found to be safe and effective for the treatment of internal contamination with plutonium, americium, or curium to increase the rates of elimination of these substances from the body (9/12/2003)
- Potassium Iodide (KI)
- Frequently Asked Questions on Potassium Iodide (KI) (2/21/2002; updated 3/29/2011)
- Potassium Iodide (KI) Information (Centers for Disease Control and Prevention)
- Guidance: Potassium Iodide as a Thyroid Blocking Agent in Radiation Emergencies (PDF - 40KB) (12/2001)
Guidance on using potassium iodide to reduce the risk of thyroid cancer in children and adults in emergencies involving the release of radioactive iodine into the environment - FDA Talk Paper: Guidance on Protection of Children and Adults Against Thyroid Cancer in Case of Nuclear Accident (12/10/2001)
- Guidance for Federal Agencies and State and Local Governments: Potassium Iodide Tablets: Shelf Life Extension (PDF - 156KB) (3/2004)
- Home Preparation Procedure for Emergency Administration of Potassium Iodide Tablets to Infants and Small Children (PDF - 33KB) (7/3/2002)
- Guidance for Industry: KI in Radiation Emergencies-Questions and Answers (PDF - 161KB) (12/20/2002)
- The Risk of Severe Allergic Reactions from the Use of Potassium Iodide for Radiation Emergencies
Position statement from the American Academy of Allergy, Asthma, and Immunology (8/16/2004)
- Prussian Blue Information
FDA approved Radiogardase, also known as Prussian blue, to treat people exposed to radiation contamination due to harmful levels of cesium-137 or thallium. (10/2/2003)- Radiogardase (Prussian Blue) Labeling (PDF - 208KB) (prescribing information for children and adults)
-
-